CC	completeness of cytoreduction score
CRS	cytoreductive surgery
CTCAE	Common Terminology Criteria for Adverse Events
ESMO	European Society for Medical Oncology
FA	folinic acid
FLOT	5-FU/leucovorin/oxaliplatin/docetaxel
5-FU	5- fluorouracil
HER2	human epidermal growth factor receptor 2
HIPEC	hyperthermic intraperitoneal chemotherapy
IPC	intraperitoneal chemotherapy
IPTW	inverse probability of treatment weighting
LAD	lymphadenectomy
MFS	metastasis-free survival
MMC	mitomycin C
MSI	microsatellite instability
NCCN	National Comprehensive Cancer Network
NICE	National Institute for Health and Care Excellence
NIPS	neoadjuvant intraperitoneal systemic chemotherapy
RCT	randomized controlled trial
NRCT	non-randomized controlled trial
OS	overall survival
PCI	Peritoneal Cancer Index
PFS	progression-free survival
PIPAC	pressurized intraperitoneal aerosol chemotherapy
pmGC	peritoneal metastatic gastric cancer
PR	partial response
RCT	randomized controlled trial
TR	total response